Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Advanced Radiotherapy Techniques, Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, and Bladder and Urothelial Cancer Treatments.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
Advancing the Paradigm: Oligometastatic Disease and the Impact of Stereotactic Ablative Body Radiotherapy
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis.
The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR)
A pilot study investigating the role of <sup>18</sup> F-FDG-PET in the early identification of chemoradiotherapy response in anal cancer.
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
Defining primary anal cancer tumour volume on FDG–PET – an initial assessment of semi–automated methods
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Radiotherapy for renal-cell carcinoma
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.